- XLO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
Xilio Therapeutics (XLO) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
13F-HR
|
Key FInancial | 830.00 | 31 Jan 25 | 31 Dec 24 | 830.00 | 0% | 30 Sep 24 |
13F-HR
|
Private Wealth Management | 310.00 | 27 Jan 25 | 31 Dec 24 | 310.00 | 0% | 30 Sep 24 |
13F-HR/A
|
JPMorgan Chase & Co. | 75.00 | 26 Dec 24 | 30 Sep 24 | 59.00 | +27% | 30 Jun 24 |
13F-HR/A
|
JPMorgan Chase & Co. | 59.00 | 26 Dec 24 | 30 Jun 24 | 2.74 k | -98% | 31 Mar 24 |
13F-HR/A
|
JPMorgan Chase & Co. | 2.74 k | 26 Dec 24 | 31 Mar 24 | 2.86 k | -4% | 31 Dec 23 |
13F-HR/A
|
JPMorgan Chase & Co. | 2.86 k | 26 Dec 24 | 31 Dec 23 | 2.72 k | +5% | 30 Sep 23 |
13F-HR
|
Dunhill Financial | 10.27 k | 15 Nov 24 | 30 Sep 24 | 10.27 k | 0% | 30 Jun 24 |
SC 13G/A
|
Bain Capital Life Sciences Fund II, L.P | 4.57 mm | 14 Nov 24 | 30 Sep 24 | 1.35 mm | +239% | 31 Dec 21 |
SC 13G/A
|
Atlas Venture Fund XI, L.P | 0.00 | 14 Nov 24 | 30 Sep 24 | 2.02 mm | -100% | 26 Oct 21 |
13F-HR
|
Millennium Management | 20.66 k | 14 Nov 24 | 30 Sep 24 | 12.21 k | +69% | 30 Jun 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.